These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 20870029)

  • 1. Prospective assessment of health-related quality of life in pediatric patients with beta-thalassemia following hematopoietic stem cell transplantation.
    Caocci G; Efficace F; Ciotti F; Roncarolo MG; Vacca A; Piras E; Littera R; Dawood Markous RS; Collins GS; Ciceri F; Mandelli F; Marktel S; La Nasa G
    Biol Blood Marrow Transplant; 2011 Jun; 17(6):861-6. PubMed ID: 20870029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life assessment in hematopoietic stem cell transplantation performed on thalassemia major patients.
    Uygun V; Tayfun F; Akcan M; Karasu GT; Kupesiz A; Hazar V; Yeşilipek A
    Pediatr Hematol Oncol; 2012 Aug; 29(5):461-71. PubMed ID: 22712884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring health-related quality of life in children with ESRD: performance of the generic and ESRD-specific instrument of the Pediatric Quality of Life Inventory (PedsQL).
    Goldstein SL; Graham N; Warady BA; Seikaly M; McDonald R; Burwinkle TM; Limbers CA; Varni JW
    Am J Kidney Dis; 2008 Feb; 51(2):285-97. PubMed ID: 18215706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cell transplant for children with sickle cell anemia: parent and patient interest.
    Roth M; Krystal J; Manwani D; Driscoll C; Ricafort R
    Biol Blood Marrow Transplant; 2012 Nov; 18(11):1709-15. PubMed ID: 22659467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired health-related quality of life in children and adolescents with chronic conditions: a comparative analysis of 10 disease clusters and 33 disease categories/severities utilizing the PedsQL 4.0 Generic Core Scales.
    Varni JW; Limbers CA; Burwinkle TM
    Health Qual Life Outcomes; 2007 Jul; 5():43. PubMed ID: 17634123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life as a predictor of pediatric healthcare costs: a two-year prospective cohort analysis.
    Seid M; Varni JW; Segall D; Kurtin PS
    Health Qual Life Outcomes; 2004 Sep; 2():48. PubMed ID: 15361252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concordance of quality of life assessments following pediatric hematopoietic stem cell transplantation.
    Feichtl RE; Rosenfeld B; Tallamy B; Cairo MS; Sands SA
    Psychooncology; 2010 Jul; 19(7):710-7. PubMed ID: 19823975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class I and II beta thalassemia major.
    Ghavamzadeh A; Iravani M; Ashouri A; Mousavi SA; Mahdavi N; Shamshiri A; Hadjibabaie M; Namdar R; Nedaeifard L; Ghaffari H; Alimoghaddam K
    Biol Blood Marrow Transplant; 2008 Mar; 14(3):301-8. PubMed ID: 18275896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life following hematopoietic stem cell transplant during childhood.
    Nuss SL; Wilson ME
    J Pediatr Oncol Nurs; 2007; 24(2):106-15. PubMed ID: 17332424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Haploidentical hematopoietic stem cell transplantation for beta-thalassemia major in children].
    Hao WG; Sun X; Liu S; Zhao Z; Chen ZX
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jul; 11(7):546-8. PubMed ID: 19650987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Allogeneic hematopoietic stem cell transplantation for beta-thalassemia major].
    Li CF; He YL; Zhang YM; Yang M; Wu XD; Bai J
    Zhonghua Xue Ye Xue Za Zhi; 2003 Apr; 24(4):174-6. PubMed ID: 12864945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting factors for admission to an intensive care unit and clinical outcome in pediatric patients receiving hematopoietic stem cell transplantation.
    Diaz MA; Vicent MG; Prudencio M; Rodriguez F; Marin C; Serrano A; Sevilla J; Casado J; Madero L
    Haematologica; 2002 Mar; 87(3):292-8. PubMed ID: 11869942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the human activity profile questionnaire in patients after allogeneic hematopoietic stem cell transplantation.
    Herzberg PY; Heussner P; Mumm FH; Horak M; Hilgendorf I; von Harsdorf S; Hemmati P; Rieger K; Greinix H; Freund M; Lee SJ; Holler E; Wolff D
    Biol Blood Marrow Transplant; 2010 Dec; 16(12):1707-17. PubMed ID: 20541028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction of the oncological pediatric risk of mortality score (O-PRISM) for ICU support following stem cell transplantation in children.
    Schneider DT; Lemburg P; Sprock I; Heying R; Göbel U; Nürnberger W
    Bone Marrow Transplant; 2000 May; 25(10):1079-86. PubMed ID: 10828869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of cumulative anthracycline dose, preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: a prospective evaluation on behalf of the EBMT Pediatric Diseases and Late Effects Working Parties.
    Uderzo C; Pillon M; Corti P; Tridello G; Tana F; Zintl F; Nysom K; Galambrun C; Fagioli F; Varotto S; Messina C; Verdeguer A; Urban C; Faraci M; Dini G; Fedeli S; Tichelli A; Rovelli A; Socié G
    Bone Marrow Transplant; 2007 Jun; 39(11):667-75. PubMed ID: 17401396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unrelated bone marrow transplantation for beta-thalassemia patients: The experience of the Italian Bone Marrow Transplant Group.
    La Nasa G; Argiolu F; Giardini C; Pession A; Fagioli F; Caocci G; Vacca A; De Stefano P; Piras E; Ledda A; Piroddi A; Littera R; Nesci S; Locatelli F
    Ann N Y Acad Sci; 2005; 1054():186-95. PubMed ID: 16339665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 12 is associated with reduced relapse without increased incidence of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Reddy V; Winer AG; Eksioglu E; Meier-Kriesche HU; Schold JD; Wingard JR
    Biol Blood Marrow Transplant; 2005 Dec; 11(12):1014-21. PubMed ID: 16338624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life, physical function, fatigue, and disease activity in children with established polyarticular juvenile idiopathic arthritis.
    Ringold S; Wallace CA; Rivara FP
    J Rheumatol; 2009 Jun; 36(6):1330-6. PubMed ID: 19411394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. French multicenter 22-year experience in stem cell transplantation for beta-thalassemia major: lessons and future directions.
    Galambrun C; Pondarré C; Bertrand Y; Loundou A; Bordigoni P; Frange P; Lutz P; Mialou V; Rubie H; Socié G; Schneider P; Bernaudin F; Paillard C; Michel G; Badens C; Thuret I; ;
    Biol Blood Marrow Transplant; 2013 Jan; 19(1):62-8. PubMed ID: 22892550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between an artificial neural network and logistic regression in predicting acute graft-vs-host disease after unrelated donor hematopoietic stem cell transplantation in thalassemia patients.
    Caocci G; Baccoli R; Vacca A; Mastronuzzi A; Bertaina A; Piras E; Littera R; Locatelli F; Carcassi C; La Nasa G
    Exp Hematol; 2010 May; 38(5):426-33. PubMed ID: 20206661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.